all report title image
  • To Be Published : Oct 2023
  • Code : CMI3183
  • Pages : N/A
  • Formats :
      Excel and PDF
  • Industry : Medical Devices

A nasolacrimal stent is considered to be a small tube used to treat conditions like epiphora and intended for use in dacryocystorhinostomy (DCR) and congenital nasolacrimal obstruction as well. Growing prevalence of nasolacrimal duct obstruction (NLDO), a common syndrome of lacrimal system, is expected to drive growth of nasal lacrimal stent market. For instance, in 2019, according to data published by the NCBI (National Center for Biotechnology Information), the prevalence for nasolacrimal duct obstruction has found around 6% to 20% in global infants.

Nasal Lacrimal Stent Market- Drivers

The nasal lacrimal stent market size is expected to increase over the forecast period owing to ongoing research on products to treat Epiphora and Dacryocystorhinostomy disease conditions. For instance, October 2019, Alon Kahana from University of Michigan sponsored a study aimed to evaluate safety and efficacy of the slit stent ii lacrimal stent for treatment of nasolacrimal duct obstruction.

Furthermore, availability of advanced products is expected to drive growth of this market. The FCI Ophthalmics Company offers products such as Nunchaku and BIKA intubation system, a bicanalicular stent which is used to drain tears by capillary.

Nasal Lacrimal Stent Market- Restraints

Alternative treatment available for epiphora medical conditions is major restraining factor of nasal lacrimal stent market. Most pharmaceuticals companies are focused on developing promising drugs which are indicated for treatment of ophthalmic diseases.  

Nasal Lacrimal Stent Market- Regional Analysis

On the basis of region, the nasal lacrimal stent market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. North America is expected to hold a dominant position in the nasal lacrimal stent market during the forecast period, as key market players are focused on expanding their presence in the North America region. For instance, in Jan, 2019, FCI Ophthalmics entered an agreement with Carl Zeiss Canada Ltd. regarding the distribution of FCI Ophthalmics' range of lacrimal stents and tubes, which include Crawford & Ritleng, Mini Monoka & new Masterka (monocanicular stent), Bika & Nunchaku (Bicanicular stent) in Canada.

Nasal Lacrimal Stent Market- Competitive Landscape

Key players operating in the nasal lacrimal stent market include FCI Ophthalmics, Kaneka Corporation, Cook Medical LLC., and Sinopsys Surgical, Inc.

Nasal Lacrimal Stent Market- Taxonomy

The nasal lacrimal stent market is segmented on the basis of product type, application, end user, and region

By Product Type

  • Bicanalicular Stents
  • Monocanalicular Stents

By Application

  • Epiphora
  • Dacryocystorhinostomy (DCR)
  • Congenital nasolacrimal obstruction

By End User 

  • Hospitals
  • Ophthalmic Surgery Centers

By Region

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East
  • Africa

  • Need a Custom Report?

    We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports

    Customize Now
  • Want to Buy a Report but have a Limited Budget?

    We help clients to procure the report or sections of the report at their budgeted price. Kindly click on the below to avail

    Request Discount

Reliability and Reputation

DUNS Registered
DMCA Protected


Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo